| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Vice President | Exec VP, Comm Optns
1 company
Boyer Andrew S is an Executive Vice President at AMRX. Recent filings cover 2 purchases and 6 sales.
Our model assigns Boyer Andrew S a below-average insider score of 28/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -45.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Executive Vice President | Sale+OE | 279,244 | $9.38 | $2,619,308.72 | -64.7% | +23.0% | +90.2% | |
| Aug 12, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Executive Vice President | Sell | 33,436 | $9.05 | $302,595.80 | -11.5% | +27.3% | +95.8% | |
| Mar 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Executive Vice President | Sell | 125,000 | $8.89 | $1,111,250.00 | -30.1% | -16.9% | +47.9% | |
| Aug 15, 2024 | AMRX Amneal Pharmaceuticals, Inc. | Executive Vice President | Sell | 62,711 | $7.84 | $491,381.91 | -19.6% | +14.2% | +19.5% | |
| Aug 11, 2023 | AMRX Amneal Pharmaceuticals, Inc. | Executive Vice President | Sell | 29,302 | $4.13 | $120,920.56 | -10.7% | +4.5% | +92.7% | |
| Aug 7, 2019 | AMRX Amneal Pharmaceuticals, Inc. | Exec VP, Comm Optns | Buy | 66,666 | $2.89 | $192,664.74 | +227.5% | - | - | |
| May 13, 2019 | AMRX Amneal Pharmaceuticals, Inc. | Exec VP, Comm Optns | Buy | 19,000 | $9.46 | $179,740.00 | +184.4% | - | - |